Expectations for Angiopoietin-like 3 Inhibitors Taking Broad Lipid-modifying Effects on the Comprehensive…

Elevated cardiovascular risk associated with hormone replacement therapy: A comprehensive analysis of reproductive factors and atherosclerotic cardiovascular disease outcomes in the UK Biobank cohort
Mengchun Wang, Can Zhang, Chunlai Yang +4
Acta Obstetricia et Gynecologica Scandinavica20 Aug 2026Peer-reviewedCC BY-NC 4.0Full textEndocrinology & metabolismPMCDOAJ
Significant Associations of Achilles Tendon Thickness With Atherosclerotic Diseases and Atherosclerotic Risk Factors in Non-Familial Hypercholesterolemia Patients: A Cross-Sectional Study
Mariko Hakoshima, Hidekatsu Yanai, Tatsuki Onomura +2
Journal of Clinical Medicine Research1 Sep 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events ― The Hokuriku-Plus Familial Hypercholesterolemia Registry Study ―
Hayato Tada, Yasuaki Takeji, Chiaki Goten +15
Circulation Journal24 Jul 2026Peer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaJ-STAGE
Economic evaluation of SGLT2 inhibitors and GLP-1 receptor agonists in Thai patients with type 2 diabetes and established atherosclerotic cardiovascular disease
Tanawan Kongmalai, Natthakan Chitpim, Varalak Srinonprasert +2
Scientific Reports6 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismCrossref
Sex differences in psychosocial burden and healthcare access among U.S. adults with premature atherosclerotic cardiovascular disease
Niti Dalal, Katherine Mills, Yilin Yoshida +3
American journal of preventive cardiology17 Jul 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{yoshida2026expectations,
  title = {{Expectations for Angiopoietin-like 3 Inhibitors Taking Broad Lipid-modifying Effects on the Comprehensive Control of Atherosclerotic Cardiovascular Disease Risk in Patients with Homozygous Familial Hypercholesterolemia}},
  author = {Hiroshi Yoshida},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2026},
  month = sep,
  doi = {10.5551/jat.ed314},
  url = {https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_ED314/_article},
  note = {CC BY-NC-SA},
}

RIS

TY  - JOUR
TI  - Expectations for Angiopoietin-like 3 Inhibitors Taking Broad Lipid-modifying Effects on the Comprehensive Control of Atherosclerotic Cardiovascular Disease Risk in Patients with Homozygous Familial Hypercholesterolemia
AU  - Hiroshi Yoshida
PY  - 2026
DA  - 2026/09/11
JO  - Journal of Atherosclerosis and Thrombosis
DO  - 10.5551/jat.ed314
UR  - https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_ED314/_article
SN  - 1880-3873
SN  - 1340-3478
ER  -

Related

Cite